AMARAJABAT2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member AMARAJABAT2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AMARAJABAT 2022-04-01 2023-03-31 2022-12-30 INR Crores Third quarter Single segment Manufacture and marketing of lead acid & other storage batteries 2022-10-01 2022-12-31 Unaudited Standalone 26372400000.00 260700000.00 26633100000.00 18241800000.00 538500000.00 -1204900000.00 1603700000.00 58400000.00 1145200000.00 3224700000.00 23607400000.00 3025700000.00 0.00 3025700000.00 763300000.00 34300000.00 797600000.00 0.00 2228100000.00 0.00 0.00 0.00 0.00 2228100000.00 -22600000.00 2205500000.00 2205500000.00 0.00 170810000.00 1 13.04 13.04 0.00 0.00 13.04 13.04 1.These financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meetings held on January 25, 2023. These results are as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The statutory auditors have carried out a limited review of these results for the quarter and nine months ended December 31, 2022 and have issued an unmodified report on such results. 2.The Company is engaged in the manufacture and marketing of lead acid and other storage batteries, which in the context of Indian Accounting Standard (Ind AS) -108 Operating Segments, is considered as the operating segment of the Company. 3.Interim dividend of Rs. 2.90 per equity share of face value of Rs. 1 each approved by the Board of Directors at its meeting held on November 3, 2022 was paid during the quarter 4.The consolidated financial results include the results of the three wholly-owned subsidiaries (i) Amara Raja Batteries Middle East (FZE) U.A.E (ii) Amara Raja Circular Solutions Private Limited ('ARCSPL') and (iii) Amara Raja Advanced Cell Technologies Private Limited ('ARACT') which was incorporated on November 29, 2022. 5. The Board of Directors of the Company at its meeting held on September 26, 2022, have approved a Scheme of Arrangement amongst Mangal Industries Limited ('Demerged Company') and Amara Raja Batteries Limited (‘ARBL’ or the ‘Resulting Company’, or the ‘Company’) and their respective shareholders and creditors, under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ( Scheme ) with an appointed date of April 1, 2022 or such other date as may be agreed. The Scheme, inter-alia, provides for demerger of the plastic component for battery business (‘Demerged Undertaking’) from the Demerged Company to the Resulting Company, and consequent issue of fully paid-up equity shares by the Company to the shareholders of the Demerged Company as per the share entitlement ratio defined in the Scheme. The Scheme is subject to the fulfilment of certain conditions including receipt of approval of shareholders (majority of public shareholders) and creditors of the Company, approval of other regulatory authorities as may be required, including those of the Stock Exchanges, Securities and Exchange Board of India (“SEBI”) and the Hon’ble jurisdictional National Company Law Tribunal (“NCLT”) and any other authority as may be applicable. As on the date of approval of these financial results by the Board, the Company has received no objection from the Stock Exchanges and NCLT process is in progress. The necessary effects of scheme would be given in the financial results in the period in which the Scheme is approved. 6. The Board of Directors of the Company at its meeting held on January 25, 2023, approved the transfer by way of sale of ‘New Energy Business’ (“NEB”) comprising of the Lithium Battery Pack Manufacturing, Cell and a state-of-the-art R&D pilot plant for prototyping, manufacturing Li-ion cells, etc., through a slump sale arrangement on a going concern basis, to its newly incorporated wholly-owned subsidiary Amara Raja Advanced Cell Technologies Private Limited (“ARACT”), at a consideration of Rs.167.2 crores (subject to adjustment as set out in the business transfer agreement). The business transfer agreement execution and closure shall be completed within a period of 4 months from the date of Board approval or such other date as may be mutually agreed, subject to completion of conditions precedent and other necessary approvals. Single segment 2022-04-01 2022-12-31 Unaudited Standalone 79567000000.00 667300000.00 80234300000.00 51486400000.00 3334900000.00 763300000.00 4446300000.00 158500000.00 3127800000.00 9356600000.00 72673800000.00 7560500000.00 0.00 7560500000.00 1902800000.00 93400000.00 1996200000.00 0.00 5564300000.00 0.00 0.00 0.00 0.00 5564300000.00 1095300000.00 6659600000.00 6659600000.00 0.00 170810000.00 1 32.58 32.58 0.00 0.00 32.58 32.58 Other Expenses 3224700000.00 Other Expenses 9356600000.00